NEW YORK (GenomeWeb) – Transplant organ diagnostic startup TAI Diagnostics today announced the completion of an $8.2 million Series A financing round and the appointment of Frank Langley as its CEO. 

Investors in the financing included Venture Investors and private investors. Proceeds will go toward the ongoing development of the Milwaukee-based company's transplant monitoring technology, clinical studies, and the creation of a reference laboratory to offer its post-transplant monitoring assays, TAI Dx said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.